Adjuvant systemic therapy in older women with breast cancer

Abstract

Breast cancer in the elderly is an increasing clinical problem. In addition, ~60% of deaths from breast cancer occur in women aged 65 years and older. Despite this, older women with breast cancer have been underrepresented in clinical trials, and this has led to less than optimal evidence to guide their therapy. The management of elderly women with early breast cancer is a complex process that requires careful evaluation of life expectancy, comorbidities, patient values, and risks and benefits of available treatment options. This review will focus on current adjuvant systemic therapy options for older women with breast cancer, discuss the principles in the decision-making process, and define the role of endocrine therapy, chemotherapy, and targeted agents.

Keywords:

• breast cancer
• adjuvant therapy
• chemotherapy
• endocrine therapy
• elderly

Acknowledgments

We want to thank the University of Iowa Libraries for the support provided for this publication.

Disclosure

The authors report no conflicts of interest in this work.